These data suggest that the miR-141-3p/C1GALT1/GLUT1 axis plays an essential role during TC progression and may be a probable biomarker or therapeutic target for thyroid cancer patients. The gene discussed is C1GALT1; the disease is thyroid gland carcinoma.